×
0 0 0 -0.0855263157894736 -0.0657894736842106 -0.0328947368421053 -0.0592105263157894 -0.0723684210526315
Analyst impact report

Eleven Biotherapeutics (NASDAQ: EBIO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $2.00 price target on the stock.

ELEVEN BIOTHERAPEUTICS (EBIO)  More Company Research Source: MarketBeat
Last eleven biotherapeutics earnings: 5/15 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.elevenbio.com/investor-relations
Impact snapshot Event time: EBIO
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
EBIO alerts
from News Quantified
Opt-in for
EBIO alerts

from News Quantified
Opt-in for
EBIO alerts

from News Quantified